Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H23N7O |
Molecular Weight | 415.4873 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[2H]C1=NC(C)=NC([2H])=C1C2=NC=NC(NC[C@@H](C)C3=C4N=CC=C(C(=O)NC)C4=CC=C3)=C2
InChI
InChIKey=PEACIOGDEQRHFA-KIYKJNLWSA-N
InChI=1S/C23H23N7O/c1-14(17-5-4-6-18-19(23(31)24-3)7-8-25-22(17)18)10-28-21-9-20(29-13-30-21)16-11-26-15(2)27-12-16/h4-9,11-14H,10H2,1-3H3,(H,24,31)(H,28,29,30)/t14-/m1/s1/i11D,12D
Molecular Formula | C23H23N7O |
Molecular Weight | 415.4873 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Targeting DNA-Dependent Protein Kinase for Cancer Therapy. | 2017 Jun 21 |
|
The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts. | 2018 Jun |
|
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells. | 2018 May 25 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:15:46 GMT 2023
by
admin
on
Sat Dec 16 11:15:46 GMT 2023
|
Record UNII |
0C33IBK195
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1476074-39-1
Created by
admin on Sat Dec 16 11:15:46 GMT 2023 , Edited by admin on Sat Dec 16 11:15:46 GMT 2023
|
PRIMARY | |||
|
0C33IBK195
Created by
admin on Sat Dec 16 11:15:46 GMT 2023 , Edited by admin on Sat Dec 16 11:15:46 GMT 2023
|
PRIMARY | |||
|
72188357
Created by
admin on Sat Dec 16 11:15:46 GMT 2023 , Edited by admin on Sat Dec 16 11:15:46 GMT 2023
|
PRIMARY | |||
|
C129061
Created by
admin on Sat Dec 16 11:15:46 GMT 2023 , Edited by admin on Sat Dec 16 11:15:46 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|